Table 2.
Fifteen genes that showed significantly higher or lower expression in renal cell carcinoma patients compared to healthy controls
| Gene | Coding protein | Fold‐change | P‐value |
|---|---|---|---|
| IFI44 | Interferon induced protein 44 like | 2.04 | 0.019 |
| MYL9 | Myosin light chain 9 | 1.78 | 0.001 |
| CMPK2 | Cytidine/uridine monophosphate kinase 2 | 1.77 | 0.032 |
| ITGB3 | Integrin α‐IIb/β‐3 | 1.72 | 0.009 |
| HERC5 | HECT and RLD domain containing e3 ubiquitin protein ligase 5 | 1.71 | 0.043 |
| ITGA2B | Integrin subunit α2b | 1.70 | 0.010 |
| TREML1 | Triggering receptor expressed on myeloid cells like 1 | 1.63 | 0.007 |
| IFIT3 | Interferon induced protein with tetratricopeptide repeats 3 | 1.61 | 0.033 |
| MX1 | MX dynamin like GTPase 1 | 1.59 | 0.039 |
| EIF2AK2 | Eukaryotic translation initiation factor 2α kinase 2 | 1.57 | 0.005 |
| SH3BGRL2 | SH3 domain binding glutamate rich protein like 2 | 1.53 | 0.011 |
| CXCL7 | C‐X‐C motif chemokine ligand 7 | 1.51 | 0.001 |
| PRKAR2B | Protein kinase CAMP‐dependent type II regulatory subunit β | 1.50 | 0.011 |
| CD79A | CD79a molecule | −1.65 | 0.022 |
| MS4A1 | Membrane spanning 4‐domains A1 | −1.67 | 0.023 |